While the evidence is still scarce, gastroenterologists can be reasonably hopeful that the use of thiopurine in IBD patients should not increase their COVID-19 risk. In a preprint version of a MJA article, South Australian gastroenterologists Dr Thomas Goodsall, Dr Sam Costello and Dr Rob Bryant said thiopurine use has previously been associated with an ...
Jury out on thiopurine & COVID-19 risk in IBD
By Mardi Chapman
4 May 2020